Silo Pharma raised about $815,000 by selling shares and pre-funded warrants at $1.50 each.

Nov 7, 2026, 9:21 AM ETNew sharesRead the original at tradingview.com

Bad for SILO

Silo Pharma received about $815,000 for company needs, but the deal adds common shares and warrants exercisable almost immediately for a tiny fee. The potential increase in shares makes this unfavorable for existing owners, though ownership limits apply.

SILO · Silo Pharma, Inc.

AI read · Bad for SILO

The AI's read

The cash gives Silo Pharma funds for company needs. But buyers can turn the warrants into shares right away for almost no additional payment, adding to the shares already sold. Ownership limits may slow when that happens, but they do not remove the possibility. The potential increase in shares weighs more heavily than the cash raised for current owners.

Get alerts for SILO

Follow Silo Pharma, Inc. (SILO) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SILO

Free on the App Store and Google Play, or on the web.